Pacific Biosciences of California, Inc. Stock
Equities
PACB
US69404D1081
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.83 USD | +3.98% | +24.49% | -81.35% |
Financials (USD)
Sales 2024 * | 193M | Sales 2025 * | 285M | Capitalization | 498M |
---|---|---|---|---|---|
Net income 2024 * | -283M | Net income 2025 * | -235M | EV / Sales 2024 * | 4.82 x |
Net Debt 2024 * | 432M | Net Debt 2025 * | 502M | EV / Sales 2025 * | 3.51 x |
P/E ratio 2024 * |
-1.76
x | P/E ratio 2025 * |
-2.17
x | Employees | 796 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.13% |
Latest transcript on Pacific Biosciences of California, Inc.
1 day | +3.98% | ||
1 week | +24.49% | ||
Current month | +10.91% | ||
1 month | -45.05% | ||
3 months | -72.89% | ||
6 months | -74.65% | ||
Current year | -81.35% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Turner
FOU | Founder | 56 | 00-07-13 |
Christian Henry
CEO | Chief Executive Officer | 56 | 18-07-31 |
Susan Kim
DFI | Director of Finance/CFO | 48 | 20-09-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Milligan
CHM | Chairman | 63 | 13-07-17 |
Marshall Mohr
BRD | Director/Board Member | 67 | 12-01-17 |
Christian Henry
CEO | Chief Executive Officer | 56 | 18-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.87% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 1.83 | +3.98% | 14,517,068 |
24-05-02 | 1.76 | +4.14% | 9,565,687 |
24-05-01 | 1.69 | +2.42% | 12,283,935 |
24-04-30 | 1.65 | +3.12% | 11,690,015 |
24-04-29 | 1.6 | +8.84% | 8,946,933 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-81.35% | 498M | |
+7.84% | 218B | |
+7.35% | 184B | |
+13.04% | 135B | |
+26.03% | 107B | |
-1.33% | 62.38B | |
+11.80% | 51.37B | |
+4.81% | 50.9B | |
+0.30% | 40.87B | |
+2.78% | 36.28B |
- Stock Market
- Equities
- PACB Stock